Multiple model (MM) dosage design: Achieving target goals with maximal precision

Proceedings of the IEEE Symposium on Computer-Based Medical Systems

Volumn , Issue , 2001, Pages 23-30

  Jelliffe, R ^a   Bayard, D ^a   Schumitzky, A ^a   Milman, M ^a   Jiang, F ^a   Leonov, S ^a   Gandhi, V ^a   Gandhi, A ^a   Botnen, A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTER SIMULATION; COMPUTER SOFTWARE; FEEDBACK; PARAMETER ESTIMATION; PATIENT MONITORING; PHYSIOLOGICAL MODELS; POPULATION STATISTICS; PROBABILITY;

CLINICAL SOFTWARE PACKAGES; INTERACTING MULTIPLE MODEL (IMM);

DRUG DOSAGE;

EID: 0034875618     PISSN: 10637125     EISSN: None     Source Type: Journal    
DOI: 10.1109/CBMS.2001.941692     Document Type: Article

References (14)

1. Role of phamacokinetics in drug dosage adjustment: 1. Pharmacologic effects. Kinetics, and apparent volume of distribution of Digoxin
2. Individualizing drug dosage regimens: Roles of population pharmacokinetic models, bayesian fitting, and adaptive control
3. Forecasting individual pharmacokinetics
4. The geometry of mixture likelihoods: A general theory
5. A maximum likelihood estimation method for random coefficient regression models
6. Nonparametric EM algorithms for estimating prior distributions
7. The nonparametric maximum likelihood approach to pharmacokinetic population analysis
8. Design of dosage regimens: A multiple model stochastic control approach
9. Precision drug dosage regimens using multiple model adaptiva control: Theory and application to simulated vancomycin therapy
10. Model-based, goal-oriented, individualized drug therapy: Linkage of population modelling, new "multiple model" dosage design, bayesian feedback, and Individualized target goals
11. Bayesian estimation of posterior densities for pharmacokinetic models having changing parameter values
12. Nonparametric estimation of population characteristics of the kinetics of lithium from observational and experimental data: Individualization of chronic dosing regimen using a new bayesian approach